These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11715766)

  • 1. The importance of postprandial glucose to treatments and outcomes in patients with type 2 diabetes.
    Herman ME; Moore RS
    Manag Care Interface; 2001 Nov; 14(11):63-9. PubMed ID: 11715766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of postprandial glucose levels with insulin in type 2 diabetes.
    Blevins T
    Postgrad Med; 2011 Jul; 123(4):135-47. PubMed ID: 21680998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes mellitus: managing hemoglobin A(1c) and beyond.
    Fowler GC; Vasudevan DA
    South Med J; 2010 Sep; 103(9):911-6. PubMed ID: 20689486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
    Fonseca V
    Curr Med Res Opin; 2003; 19(7):635-41. PubMed ID: 14606987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of diabetes and the relationship of dglucose to kidney function.
    Mandal AK; Hiebert L
    Curr Diabetes Rev; 2015; 11(2):116-21. PubMed ID: 25732030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
    Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.
    Abrahamson MJ
    Arch Intern Med; 2004 Mar; 164(5):486-91. PubMed ID: 15006824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
    Bastyr EJ; Stuart CA; Brodows RG; Schwartz S; Graf CJ; Zagar A; Robertson KE
    Diabetes Care; 2000 Sep; 23(9):1236-41. PubMed ID: 10977012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain.
    Lecumberri Pascual E; Tejera Pérez C; Muñoz-Garach A; Javier Ampudia-Blasco F
    Diabetes Res Clin Pract; 2019 Aug; 154():43-51. PubMed ID: 31226281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study.
    Zhang B; Zhao J; Yang W;
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
    Woerle HJ; Neumann C; Zschau S; Tenner S; Irsigler A; Schirra J; Gerich JE; Göke B
    Diabetes Res Clin Pract; 2007 Aug; 77(2):280-5. PubMed ID: 17240473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
    Yki-Järvinen H; Dressler A; Ziemen M;
    Diabetes Care; 2000 Aug; 23(8):1130-6. PubMed ID: 10937510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial glucose regulation: new data and new implications.
    Leiter LA; Ceriello A; Davidson JA; Hanefeld M; Monnier L; Owens DR; Tajima N; Tuomilehto J;
    Clin Ther; 2005; 27 Suppl B():S42-56. PubMed ID: 16519037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on the AACE/ACE statement on glycemic control for patients with type 2 diabetes mellitus.
    Eledrisi M
    Endocr Pract; 2010; 16(1):130-1; author reply 131-2. PubMed ID: 20146995
    [No Abstract]   [Full Text] [Related]  

  • 17. Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective.
    Senior P; Hramiak I
    Can J Diabetes; 2019 Oct; 43(7):515-523. PubMed ID: 30872107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fasting capillary glucose variability between insulin glargine and NPH.
    Mu P; Lu H; Zhang G; Chen Y; Fu J; Wang M; Shu J; Zeng L
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e4-7. PubMed ID: 20970870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes.
    Tibaldi J
    South Med J; 2009 Jan; 102(1):60-6. PubMed ID: 19077774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes.
    Aronoff SL
    Postgrad Med; 2017 Mar; 129(2):231-241. PubMed ID: 28118069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.